← Back to all signals

ASTH Astrana Health, Inc.

Last updated: Nov 16, 2026

—

Execution Consistency

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 2/4 quarters. Q3 2026: $1M, Q1 2025: $3M, Q3 2025: $0M, Q2 2025: $-3M

🐂

Execution Acceleration

Is the most recent quarter's buyback spend more than 15% above the trailing average?

New buyback activity: $1M after no prior spending

—

Buyback vs FCF

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Buyback $1M / FCF $170M = 1% of FCF

—

Buyback Intensity

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 702,741 shares = 1.5% of 46,575,699 outstanding (annualized)

🐻

Insider Buying

Are officers and directors buying stock with their own money on the open market?

No insider open-market purchases in the last 12 months

—

Insider-Buyback Convergence

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

Need both buyback and insider purchase data

—

Insider Net Direction

Over the last 90 days, are insiders net buyers or net sellers on the open market?

No insider open-market transactions in the last 90 days

—

Red Flag

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected